• LAST PRICE
    6.8400
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    6.5400/ 50
  • Ask / Lots
    7.0000/ 20
  • Open / Previous Close
    0.0000 / 6.8400
  • Day Range
    ---
  • 52 Week Range
    Low 3.6800
    High 7.9600
  • Volume
    ---
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 6.81
TimeVolumeSCPH
09:32 ET18356.9
09:33 ET8006.9
09:35 ET4006.9
09:42 ET3006.85
09:44 ET15006.85
09:46 ET7506.8304
09:48 ET7006.9346
09:55 ET53636.9599
09:57 ET1857.005
10:00 ET9856.9872
10:02 ET1006.98
10:06 ET2006.95
10:08 ET1007.025
10:09 ET2357.05
10:11 ET7007.02
10:13 ET4507.005
10:15 ET17927.05
10:18 ET5007.0942
10:26 ET5997.1178
10:31 ET5007.08
10:40 ET4007.08
10:44 ET19537.07
10:45 ET3007.095
10:47 ET4007.07
10:49 ET10007.01
10:54 ET1007.025
10:56 ET2007.025
11:00 ET1007
11:02 ET7087
11:09 ET4136.97
11:18 ET4776.955
11:20 ET2006.95
11:21 ET1006.93
11:23 ET1006.95
11:25 ET30576.95
11:27 ET51286.92
11:34 ET11006.885
11:36 ET4006.88
11:38 ET1006.885
11:39 ET3006.885
11:41 ET3006.865
11:43 ET2276.8636
11:45 ET164336.77
11:48 ET15516.8
11:50 ET49696.78
11:52 ET2006.78
11:54 ET4006.8
11:56 ET3086.8
11:57 ET16006.78
12:01 ET2006.79
12:03 ET3006.7899
12:08 ET27006.79
12:10 ET4006.79
12:12 ET64006.8
12:14 ET1006.795
12:17 ET2006.8
12:21 ET10006.8081
12:24 ET18376.8
12:28 ET1006.7875
12:30 ET2006.795
12:32 ET4006.8
12:33 ET8626.8
12:37 ET4006.795
12:39 ET1006.7875
12:48 ET9066.79
12:51 ET11006.8
12:53 ET1006.8
12:55 ET14006.8
01:00 ET1006.795
01:02 ET1006.795
01:08 ET7636.8
01:09 ET51276.74
01:11 ET6006.74
01:13 ET17916.73
01:26 ET10066.75
01:27 ET175046.8
01:29 ET2006.8
01:31 ET13006.8099
01:33 ET2006.8
01:36 ET1006.8
01:40 ET57016.86
01:44 ET10006.86
01:45 ET1006.9
01:47 ET6006.875
01:51 ET10006.8401
01:54 ET4006.87
01:56 ET1006.87
01:58 ET3006.875
02:00 ET31226.8555
02:02 ET2006.865
02:03 ET1016.89
02:05 ET3006.9231
02:07 ET2076.88
02:09 ET8306.88
02:12 ET66386.8601
02:14 ET1006.815
02:16 ET1006.815
02:20 ET4006.82
02:21 ET2006.85
02:23 ET8006.825
02:25 ET3006.8
02:32 ET5636.825
02:38 ET6006.825
02:41 ET7646.825
02:43 ET1006.8
02:45 ET3006.82
02:48 ET3006.82
02:50 ET6006.82
02:52 ET3006.82
02:54 ET4006.825
02:56 ET2006.825
02:57 ET7006.81
03:03 ET8006.825
03:06 ET5006.81
03:08 ET6006.81
03:10 ET14506.81
03:12 ET8186.81
03:14 ET5006.81
03:15 ET3006.81
03:17 ET10006.81
03:19 ET9106.81
03:21 ET13006.81
03:24 ET2006.81
03:26 ET15006.81
03:28 ET4006.81
03:30 ET10006.815
03:32 ET40066.815
03:33 ET8106.815
03:35 ET19106.815
03:37 ET17006.815
03:39 ET21006.815
03:42 ET6836.815
03:44 ET8746.815
03:48 ET14806.81
03:50 ET4006.815
03:51 ET131066.82
03:53 ET40936.82
03:55 ET20006.835
03:57 ET22006.83
04:00 ET33336.84
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesSCPH
scPharmaceuticals Inc
232.7M
-4.7x
---
United StatesNUNZ
Nunzia Pharmaceutical Corp
141.1M
-1.5x
---
United StatesMRNS
Marinus Pharmaceuticals Inc
209.9M
-9.9x
---
United StatesSEEL
Seelos Therapeutics Inc
115.7M
-1.4x
---
United StatesBGXX
Bright Green Corp
96.5M
-3.4x
---
United StatesVRCA
Verrica Pharmaceuticals Inc
139.3M
-3.3x
---
As of 2022-12-09

Company Information

scPharmaceuticals Inc. is a pharmaceutical company. The Company is focused on developing and commercializing products that are designed to reduce healthcare costs and improve health outcomes. The Company develops, internally and through strategic partnerships, products and solutions that aim to expand and advance the outpatient care of select acute conditions. Its lead product candidate, FUROSCIX, consists of its formulation of furosemide delivered via an on-body infusor and is under development for treatment of edema in adult patients with congestive heart failure, cirrhosis of the liver and renal disease, including nephrotic syndrome. Its pipeline programs also include scCeftriaxone and scCarbapenem. Its scCeftriaxone is an antibiotic used intravenously for the treatment of infections caused by gram-positive and gram-negative organisms. Its scCarbapenem program is an antibiotic used intravenously for the treatment of infections caused by gram-negative organisms.

Contact Information

Headquarters
2400 District Avenue, Suite 310BURLINGTON, MA, United States 01803
Phone
617-517-0730
Fax
302-655-5049

Executives

Independent Chairman of the Board
Jack Khattar
President, Chief Executive Officer, Principal Executive Officer, Principal Financial Officer, Director
John Tucker
Senior Vice President - Finance, Principal Accounting Officer
Rachael Nokes
Independent Director
William Abraham
Independent Director
Mette Agger

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$232.7M
Revenue (TTM)
$0.00
Shares Outstanding
34.0M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.26
EPS
$-1.46
Book Value
$2.06
P/E Ratio
-4.7x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.